Publisher: Adis International
ISSN: 1175-2203
Source: American Journal of PharmacoGenomics, Vol.3, Iss.3, 2003-01, pp. : 181-191
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Direct medical costs and their predictors in patients with rheumatoid arthritis
Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. :
Clinical safety of tocilizumab in rheumatoid arthritis
By Bannwarth Bernard Richez Christophe
Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. :
Rheumatoid arthritis: assessing disease activity and outcome
Clinical Medicine, Vol. 10, Iss. 3, 2010-06 ,pp. :